Please login to the form below

Not currently logged in
Email:
Password:

Joint ownership for Indigenus network

Thirteen agencies pool resources to provide global creative services to healthcare clients

The 13 independent agencies in the Indigenus network have formally pooled their resources to provide a global creative service to healthcare clients by becoming a limited liability company (LLC).

By unifying under a joint-ownership structure, the founding partners believe that they can offer clients delivery of inspired creative and strategic thinking.

With a network spanning both major and emerging global markets, Indigenus helps pharmaceutical and healthcare companies in the fields of multichannel global branding, advertising, medical education and medical communications. It has local agency teams that work in partnership with global brand teams.

"Indigenus has always brought together the best entrepreneurial brains in the business," said Rico Viray, founding partner of Indigenus and The CementBloc in New York, US. "Clients know they can get consistently superior thinking from independent creative agencies, and we join forces to allow clients to tap into this kind of service on a global basis."

The 13 agencies are: The CementBloc (US), PAN Advertising (UK), Umbilical (Spain), Strategik & Numerik (France), Serviceplan (Germany), thenewway (Italy), Marketing Latino (Mexico), Sorento Health (India), Graphinn (Turkey), me&lewis (Canada), Lindh & Partners (Sweden), PharMa International (Japan) and Micó Publicidad (Argentina).

The Indigenus Transcreation Center (ITC), based in New York, US, caters for the emerging markets via its culturally sensitive adaptation and translation services to manage cost-efficient rollouts across local markets. It has a 200-country virtual network.

Indigenus was founded in 2004 to provide an alternative to traditional advertising agency conglomerates. In 2011, Indigenus will continue to expand its network and has potential agency partners in Brazil, Australia, China, and Russia.

14th April 2011

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Fishawack Group of Companies

The Fishawack Group of Companies is one of the largest independent medical communications and medical marketing specialists, with teams in...

Latest intelligence

2019: CRISPR and therapeutic gene editing comes of age
Can gene-editing deliver safe and effective therapeutics for patients with intractable diseases?...
The 10-year Web Challenge
Understanding your users’ needs is more critical online today than ever. A site should mould itself around these insights, deliver those needs quickly, efficiently and with plenty of white space....
Downloadable Pack: Understanding Multiple Sclerosis
Inside this downloadable pack, you’ll find a wealth of exclusive information on the way multiple sclerosis is commonly treated today. As well as areas of continuous improvement for the industry....

Infographics